Susan Richards Windham-Bannister - Jun 9, 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Susan Richards Windham-Bannister by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 04:22 PM
Previous filing
Jun 3, 2022
Next filing
Dec 7, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +8.5K $0.00 8.5K Jun 9, 2022 Common Stock 8.5K $4.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.